UnknownPhase 4

Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients

Belgium15 participantsStarted 2016-03

Plain-language summary

To validate blood draws via a central venous catheter (Port A Cath ®) for pharmacokinetic studies of ciprofloxacin in patients under treatment for childhood cancer.

Who can participate

Age range1 Month – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Children who * are between 1 month and 18 years of age * are under treatment for any type of childhood cancer * use ciprofloxacin for prophylaxis of febrile neutropenia as part of regular treatment * have a PAC for intravenous medication and blood draws. Exclusion Criteria: Children will be excluded from this study if we are unable to * obtain informed consent of both parents and assent of the child (if he/she is over 12 years of age) * aspire blood from the PAC.

What they're measuring

Correlation between ciprofloxacin concentration drawn via Port a Cath (PAC) versus capillary/venous punction

Timeframe: 1 hour

Trial details

NCT IDNCT02967341

SponsorUniversitair Ziekenhuis Brussel

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-03

Contact for this trial

Kevin Meesters, MD MPH

kevin.meesters@uzbrussel.be

View on ClinicalTrials.gov More Childhood Cancer trials